• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta‑analysis.

作者信息

Obasi Mary, Abovich Arielle, Vo Jacqueline B, Gao Yawen, Papatheodorou Stefania I, Nohria Anju, Asnani Aarti, Partridge Ann H

机构信息

Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA.

Department of Medicine, Johns Hopkins Hospital, Baltimore, MD, USA.

出版信息

Cancer Causes Control. 2021 Dec;32(12):1407-1409. doi: 10.1007/s10552-021-01495-1.

DOI:10.1007/s10552-021-01495-1
PMID:34533664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9172661/
Abstract
摘要

相似文献

1
Correction to: Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta‑analysis.对《他汀类药物减轻接受蒽环类药物和/或曲妥珠单抗治疗的癌症患者的心脏毒性：一项系统评价和荟萃分析》的更正
Cancer Causes Control. 2021 Dec;32(12):1407-1409. doi: 10.1007/s10552-021-01495-1.
2
Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.在早期乳腺癌接受蒽环类药物或曲妥珠单抗化疗后，他汀类药物暴露与心力衰竭风险：倾向评分匹配队列研究。
J Am Heart Assoc. 2021 Jan 19;10(2):e018393. doi: 10.1161/JAHA.119.018393. Epub 2021 Jan 6.
3
Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.化疗治疗乳腺癌患者的心脏毒性和心脏监测。
JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093. doi: 10.1016/j.jcmg.2018.06.005.
4
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.评估超声心动图和生物标志物在接受蒽环类药物、紫杉烷类药物和曲妥珠单抗治疗的患者中心脏毒性的扩展预测。
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. doi: 10.1161/CIRCIMAGING.112.973321. Epub 2012 Jun 28.
5
Meta-analysis Evaluating the Use of Statins to attenuate Cardiotoxicity in Cancer Patients receiving Anthracyclines and Trastuzumab-based Chemotherapy.评估他汀类药物在接受蒽环类药物和曲妥珠单抗化疗的癌症患者中减轻心脏毒性作用的荟萃分析。
Am J Cardiol. 2021 Oct 1;156:142-145. doi: 10.1016/j.amjcard.2021.07.001. Epub 2021 Aug 3.
6
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab.SAFE试验：一项正在进行的随机临床研究，旨在评估在接受蒽环类药物治疗（无论是否联合曲妥珠单抗）的乳腺癌患者中预防心脏毒性的作用。
Med Oncol. 2017 May;34(5):75. doi: 10.1007/s12032-017-0938-x. Epub 2017 Mar 31.
7
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy.曲妥珠单抗治疗 HER2 阳性乳腺癌患者的他汀类药物的心脏保护作用。
Can J Cardiol. 2019 Feb;35(2):153-159. doi: 10.1016/j.cjca.2018.11.028. Epub 2018 Dec 4.
8
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.化疗治疗患者中心脏毒性的早期检测和预测。
Am J Cardiol. 2011 May 1;107(9):1375-80. doi: 10.1016/j.amjcard.2011.01.006. Epub 2011 Mar 2.
9
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.早期乳腺癌中体质量指数与蒽环类药物和曲妥珠单抗相关心脏毒性的关系：法国 CANTO 队列研究。
PLoS Med. 2019 Dec 23;16(12):e1002989. doi: 10.1371/journal.pmed.1002989. eCollection 2019 Dec.
10
[Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab].[肌钙蛋白I和B型利钠肽（BNP）作为预测接受辅助蒽环类药物和曲妥珠单抗治疗的乳腺癌患者心脏毒性的生物标志物]
Clin Ter. 2015;166(1):e67-71. doi: 10.7417/CT.2015.1812.

引用本文的文献

1
Association of cancer treatment with excess heart age among five-year young breast cancer survivors.五年期年轻乳腺癌幸存者的癌症治疗与心脏年龄超标之间的关联。
J Cancer Surviv. 2024 Jul 15. doi: 10.1007/s11764-024-01645-9.
2
Role and molecular mechanism of traditional Chinese medicine in preventing cardiotoxicity associated with chemoradiotherapy.中药在预防放化疗相关心脏毒性中的作用及分子机制
Front Cardiovasc Med. 2022 Nov 7;9:1047700. doi: 10.3389/fcvm.2022.1047700. eCollection 2022.
3
The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment.曲妥珠单抗诱导的心脏毒性在HER-2阳性乳腺癌治疗中的研究进展
Front Cardiovasc Med. 2022 Jan 12;8:821663. doi: 10.3389/fcvm.2021.821663. eCollection 2021.